Illuminating the dark side of neuraminidase in influenza immunity
The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "univers...
Gespeichert in:
Veröffentlicht in: | Immunity (Cambridge, Mass.) Mass.), 2023-11, Vol.56 (11), p.2463-2465 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2465 |
---|---|
container_issue | 11 |
container_start_page | 2463 |
container_title | Immunity (Cambridge, Mass.) |
container_volume | 56 |
creator | Ippolito, Gregory C. |
description | The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines. |
doi_str_mv | 10.1016/j.immuni.2023.10.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2890758452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2890758452</sourcerecordid><originalsourceid>FETCH-LOGICAL-c233t-def448f448c15b205163de28083324fd38f835fbf122e032963a8344df9cb3c83</originalsourceid><addsrcrecordid>eNotkE1PwzAMhiMEEmPwDzjkyKXFidM2PU4TH5MmcYFzlDUJZLTpSNrD-PW0KpItW69f2dZDyD2DnAErH4-577ox-JwDx0nKgfELsmJQV5lgEi7nvhJZVTK8JjcpHQGYKGpYkc2ubcfOBz348EmHL0uNjt80eWNp72iwY9TT2BudLPVhCteONvxqupwczrfkyuk22bv_uiYfz0_v29ds__ay2272WcMRh8xYJ4Scs2HFgUPBSjSWS5CIXDiD0kks3MExzi0gr0vUEoUwrm4O2Ehck4dl7yn2P6NNg-p8amzb6mD7MSkua6gKKQo-WcVibWKfUrROnaLvdDwrBmompo5qeV_NxGZ1IoZ_GkxgyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2890758452</pqid></control><display><type>article</type><title>Illuminating the dark side of neuraminidase in influenza immunity</title><source>Elsevier ScienceDirect Journals Complete</source><source>Open Access: Cell Press Free Archives</source><source>EZB Electronic Journals Library</source><creator>Ippolito, Gregory C.</creator><creatorcontrib>Ippolito, Gregory C.</creatorcontrib><description>The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.</description><identifier>ISSN: 1074-7613</identifier><identifier>EISSN: 1097-4180</identifier><identifier>DOI: 10.1016/j.immuni.2023.10.012</identifier><language>eng</language><ispartof>Immunity (Cambridge, Mass.), 2023-11, Vol.56 (11), p.2463-2465</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c233t-def448f448c15b205163de28083324fd38f835fbf122e032963a8344df9cb3c83</cites><orcidid>0000-0002-7565-7002</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids></links><search><creatorcontrib>Ippolito, Gregory C.</creatorcontrib><title>Illuminating the dark side of neuraminidase in influenza immunity</title><title>Immunity (Cambridge, Mass.)</title><description>The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.</description><issn>1074-7613</issn><issn>1097-4180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNotkE1PwzAMhiMEEmPwDzjkyKXFidM2PU4TH5MmcYFzlDUJZLTpSNrD-PW0KpItW69f2dZDyD2DnAErH4-577ox-JwDx0nKgfELsmJQV5lgEi7nvhJZVTK8JjcpHQGYKGpYkc2ubcfOBz348EmHL0uNjt80eWNp72iwY9TT2BudLPVhCteONvxqupwczrfkyuk22bv_uiYfz0_v29ds__ay2272WcMRh8xYJ4Scs2HFgUPBSjSWS5CIXDiD0kks3MExzi0gr0vUEoUwrm4O2Ehck4dl7yn2P6NNg-p8amzb6mD7MSkua6gKKQo-WcVibWKfUrROnaLvdDwrBmompo5qeV_NxGZ1IoZ_GkxgyQ</recordid><startdate>20231114</startdate><enddate>20231114</enddate><creator>Ippolito, Gregory C.</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7565-7002</orcidid></search><sort><creationdate>20231114</creationdate><title>Illuminating the dark side of neuraminidase in influenza immunity</title><author>Ippolito, Gregory C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c233t-def448f448c15b205163de28083324fd38f835fbf122e032963a8344df9cb3c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ippolito, Gregory C.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Immunity (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ippolito, Gregory C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Illuminating the dark side of neuraminidase in influenza immunity</atitle><jtitle>Immunity (Cambridge, Mass.)</jtitle><date>2023-11-14</date><risdate>2023</risdate><volume>56</volume><issue>11</issue><spage>2463</spage><epage>2465</epage><pages>2463-2465</pages><issn>1074-7613</issn><eissn>1097-4180</eissn><abstract>The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.</abstract><doi>10.1016/j.immuni.2023.10.012</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-7565-7002</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1074-7613 |
ispartof | Immunity (Cambridge, Mass.), 2023-11, Vol.56 (11), p.2463-2465 |
issn | 1074-7613 1097-4180 |
language | eng |
recordid | cdi_proquest_miscellaneous_2890758452 |
source | Elsevier ScienceDirect Journals Complete; Open Access: Cell Press Free Archives; EZB Electronic Journals Library |
title | Illuminating the dark side of neuraminidase in influenza immunity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-06T14%3A40%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Illuminating%20the%20dark%20side%20of%20neuraminidase%20in%20influenza%20immunity&rft.jtitle=Immunity%20(Cambridge,%20Mass.)&rft.au=Ippolito,%20Gregory%20C.&rft.date=2023-11-14&rft.volume=56&rft.issue=11&rft.spage=2463&rft.epage=2465&rft.pages=2463-2465&rft.issn=1074-7613&rft.eissn=1097-4180&rft_id=info:doi/10.1016/j.immuni.2023.10.012&rft_dat=%3Cproquest_cross%3E2890758452%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2890758452&rft_id=info:pmid/&rfr_iscdi=true |